Broadcast Date: August 4, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Induced pluripotent stem cells (iPSCs) have revolutionized life sciences research efforts, especially when trying to understand the underlying causes of debilitating human diseases. Combining iPSC technology with cutting-edge genome editing methodologies provides a unique opportunity for investigators to create an array of disease models that will become integral for developing new therapeutic approaches. We have already seen a steady rise in the use of human iPSCs for disease modeling, which, initiating in academia, have now infiltrated the biopharmaceutical industry. In this GEN webinar, we will provide a field overview of how iPSCs, coupled with genome editing, hold the potential to expand our understanding of human diseases further and facilitate the development of new therapies.
A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.
Produced with support from:
Elena Matsa, PhD
Associate Product Manager,
Cell Line Products